Skip to main content
VALIRX PLC logo

VALIRX PLC — Investor Relations & Filings

Ticker · VAL ISIN · GB00BLH13C52 LEI · 213800VQKB9SJCQDET40 IL Professional, scientific and technical activities
Filings indexed 574 across all filing types
Latest filing 2017-05-30 AGM Information
Country GB United Kingdom
Listing IL VAL

About VALIRX PLC

https://www.valirx.com/

ValiRx PLC is a life science company that accelerates the development of therapeutics and diagnostics, with a primary focus on oncology and women's health. The company's business model centers on identifying and progressing promising early-stage scientific discoveries through pre-clinical and clinical development. ValiRx provides scientific, financial, and commercial expertise to translate novel research into clinically validated treatments, aiming to improve patient outcomes in its target therapeutic areas.

Recent filings

Filing Released Lang Actions
Result of AGM
AGM Information Classification · 99% confidence The document explicitly states 'RESULT OF ANNUAL GENERAL MEETING' and confirms that 'all resolutions were duly passed' at the AGM held on May 30, 2017. This directly corresponds to the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting. Although it is a result announcement, the content is intrinsically tied to the AGM proceedings, making AGM-R the most specific fit over a general Regulatory Filing (RNS) or Declaration of Voting Results (DVA), as DVA is usually for the formal declaration of results, whereas this document confirms the outcome of the meeting itself.
2017-05-30 English
NOTIFICATION OF AUSTRALIAN PATENT ALLOWANCE
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated May 24, 2017. It announces a specific corporate event: the allowance of an Australian patent for a therapeutic compound (VAL401). The text explicitly states, 'This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014' and concludes with 'This information is provided by RNS The company news service from the London Stock Exchange END'. This structure is characteristic of a general regulatory news service announcement, which falls under the 'Regulatory Filings' category (RNS) as it is a broad announcement of material information not specifically covered by other detailed categories like ER, 10-K, or DIV. It is not a full report, presentation, or transcript.
2017-05-24 English
Notice of AGM
Report Publication Announcement Classification · 100% confidence The document is an RNS announcement (indicated by 'RNS Number : 3902E' and the closing signature 'This information is provided by RNS'). The primary purpose of this announcement is to state that the 'Annual Report and Accounts' and the 'Notice of Annual General Meeting' have been published and posted to shareholders. According to Rule 2 ('THE "MENU VS MEAL" RULE'), when a document announces the publication of a report (like the Annual Report) rather than containing the full report itself, it should be classified as a Report Publication Announcement (RPA). Although it mentions the AGM Notice (which could suggest AGM-R), the core action described is the *posting* and *availability* of multiple documents, making RPA the most accurate classification for this announcement wrapper. The document length (3344 chars) is short, supporting the RPA classification over the full 10-K or AGM-R.
2017-05-05 English
Final Results
Earnings Release Classification · 100% confidence The document explicitly states, 'FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2016' and includes detailed sections like 'CHAIRMAN'S STATEMENT FOR THE YEAR ENDED 31 DECEMBER 2016' and 'CHIEF EXECUTIVE'S REPORT FOR THE YEAR ENDED 31 DECEMBER 2016'. It covers comprehensive operational and financial performance for a full fiscal year, including net operating loss figures and R&D cost comparisons between 2016 and 2015. This structure and content strongly indicate a full annual financial report, which corresponds to the 10-K filing type, even though it is presented via an RNS announcement (RNS Number : 2546E). Since the document contains the full results and management discussion, it is classified as the report itself, not just the announcement of the report (RPA). FY 2016
2017-05-05 English
Re: SHARES Magazine Supplement on ValiRx website
Report Publication Announcement Classification · 99% confidence The document is a short announcement (3222 characters) released via RNS (RNS Number : 5389D). The core message is that a supplement titled "ValiRx And The Drug Development Journey," published by Shares Magazine, is now available on the company's website. This fits the definition of announcing the publication or availability of a report/article, rather than being the report itself. According to Rule 2 (The "MENU VS MEAL" Rule), when a document is short and announces that a report has been published or is available, it should be classified as a Report Publication Announcement (RPA).
2017-04-27 English
Change of Registered Office
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and is dated April 19, 2017. The content announces a 'Change of Registered Office' for ValiRx Plc. This is a specific, non-financial corporate event announcement. It is not an Annual Report (10-K), Earnings Release (ER), or a comprehensive Interim Report (IR). Since it is a formal announcement disseminated via the RNS system (London Stock Exchange's news service) regarding a minor administrative change, and it doesn't fit into the more specific categories like Director's Dealing (DIRS), Dividend (DIV), or Capital Change (CAP), the most appropriate classification is the general Regulatory Filings category (RNS), which serves as a fallback for miscellaneous regulatory announcements.
2017-04-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.